BlackRock
DXCM icon

BlackRock’s DexCom DXCM Stock Holding History

BlackRock’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-272,000
Closed -$37.7M – 5302
2024
Q1 		$37.7M Buy
+272,000
New +$34.2M ﹤0.01% 2617
2023
Q1 		– Sell
-347,000
Closed -$39.3M – 5603
2022
Q4 		$39.3M Hold
347,000
– – ﹤0.01% 2630
2022
Q3 		$27.9M Buy
+347,000
New +$29.4M ﹤0.01% 2844
2022
Q1 		– Sell
-238,800
Closed -$32.1M – 5835
2021
Q4 		$32.1M Sell
238,800
-2,800
-1% -$402K ﹤0.01% 2981
2021
Q3 		$33M Buy
+241,600
New +$30.5M ﹤0.01% 2934

Other funds holding DXCM

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock's DXCM Position: Q2 2026 in Review

BlackRock reduced its DexCom (DXCM) stake by 1.8% in Q2 2026, selling an estimated $48M and leaving 38,244,137 shares worth $2.58B. The position accounts for 0.04% of the portfolio, ranked #371.

BlackRock first reported a position in DXCM in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.71B in Q1 2024. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • BlackRock held 38,244,137 shares of DexCom worth $2.58B as of Q2 2026.
  • BlackRock sold 720,234 DexCom shares in Q2 2026, an estimated $48M.
  • DexCom made up 0.04% of BlackRock's portfolio in Q2 2026, its #371 holding.
  • BlackRock first reported a position in DexCom in Q2 2013 and has held it in 53 quarters since.
  • BlackRock's DexCom position peaked at $4.71B in Q1 2024.
  • 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.